RBD206-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern

被引：0
|
作者：
Chuge Zhou
Xiaodong Zai
Ziqing Zhou
Ruihua Li
Yue Zhang
Yaohui Li
Ying Yin
Jun Zhang
Junjie Xu
Wei Chen
机构：
[1] Beijing Institute of Biotechnology,
来源：
Signal Transduction and Targeted Therapy | / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastoris
    Zhao, Tongxin
    Liu, Sheng
    Wang, Pengyan
    Zhang, Yanfang
    Kang, Xinrui
    Pan, Xiaoqian
    Li, Linjie
    Li, Dedong
    Gao, Ping
    An, Yaling
    Song, Hao
    Liu, Kefang
    Qi, Jianxun
    Zhao, Xin
    Dai, Lianpan
    Liu, Peipei
    Wang, Peiyi
    Wu, Guizhen
    Zhu, Taicheng
    Xu, Kun
    Li, Yin
    Gao, George F.
    PLOS PATHOGENS, 2024, 20 (08)
  • [42] Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
    Wang, Siling
    Sun, Hui
    Zhang, Yali
    Yuan, Lunzhi
    Wang, Yizhen
    Zhang, Tianying
    Wang, Shaojuan
    Zhang, Jinlei
    Yu, Hai
    Xiong, Hualong
    Tang, Zimin
    Liu, Liqin
    Huang, Yang
    Chen, Xiuting
    Li, Tingting
    Ying, Dong
    Liu, Chang
    Chen, Zihao
    Yuan, Quan
    Zhang, Jun
    Cheng, Tong
    Li, Shaowei
    Guan, Yi
    Zheng, Qingbing
    Zheng, Zizheng
    Xia, Ningshao
    CELL REPORTS, 2022, 39 (08):
  • [43] Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
    Santos da Silva, Eveline
    Servais, Jean-Yves
    Kohnen, Michel
    Arendt, Vic
    Staub, Therese
    Kruger, Rejko
    Fagherazzi, Guy
    Wilmes, Paul
    Hubschen, Judith M.
    Ollert, Markus
    Perez-Bercoff, Danielle
    Seguin-Devaux, Carole
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [44] A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern
    Jingyi Yang
    Mei-Qin Liu
    Lin Liu
    Xian Li
    Mengxin Xu
    Haofeng Lin
    Shuning Liu
    Yunqi Hu
    Bei Li
    Bowen Liu
    Min Li
    Ying Sun
    Yao-Qing Chen
    Zheng-Li Shi
    Huimin Yan
    Cellular & Molecular Immunology, 2022, 19 : 1279 - 1289
  • [45] Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H
    Zeng, Cong
    Evans, John P.
    Faraone, Julia N.
    Qu, Panke
    Zheng, Yi-Min
    Saif, Linda
    Oltz, Eugene M.
    Lozanski, Gerard
    Gumina, Richard J.
    Liu, Shan-Lu
    MBIO, 2021, 12 (05):
  • [46] A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
    Mitch Brinkkemper
    Philip J. M. Brouwer
    Pauline Maisonnasse
    Marloes Grobben
    Tom G. Caniels
    Meliawati Poniman
    Judith A. Burger
    Ilja Bontjer
    Melissa Oomen
    Joey H. Bouhuijs
    Cynthia A. van der Linden
    Julien Villaudy
    Yme U. van der Velden
    Kwinten Sliepen
    Marit J. van Gils
    Roger Le Grand
    Rogier W. Sanders
    npj Vaccines, 6
  • [47] The emerging SARS-CoV-2 variants of concern
    Sanyaolu, Adekunle
    Okorie, Chuku
    Marinkovic, Aleksandra
    Haider, Nafees
    Abbasi, Abu Fahad
    Jaferi, Urooj
    Prakash, Stephanie
    Balendra, Vyshnavy
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [48] A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
    Brinkkemper, Mitch
    Brouwer, Philip J. M.
    Maisonnasse, Pauline
    Grobben, Marloes
    Caniels, Tom G.
    Poniman, Meliawati
    Burger, Judith A.
    Bontjer, Ilja
    Oomen, Melissa
    Bouhuijs, Joey H.
    van der Linden, Cynthia A.
    Villaudy, Julien
    van der Velden, Yme U.
    Sliepen, Kwinten
    van Gils, Marit J.
    Le Grand, Roger
    Sanders, Rogier W.
    NPJ VACCINES, 2021, 6 (01)
  • [49] The origin of SARS-CoV-2 variants of concern
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2022, 22 (02): : 174 - 175
  • [50] SARS-CoV-2 variants of concern: a review
    Sarkar, Malay
    Madabhavi, Irappa
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
12345